• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMJ Open Respir Res . Long-term multidimensional patient-centred outcomes after hospitalisation for COVID-19: do not only focus on disease severity

tetano

Editor, Senior Moderator
BMJ Open Respir Res


. 2025 Jun 8;12(1):e002789.
doi: 10.1136/bmjresp-2024-002789. Long-term multidimensional patient-centred outcomes after hospitalisation for COVID-19: do not only focus on disease severity

Martine Bek[SUP] 1 [/SUP], Yasemin Türk[SUP] 2 [/SUP], Matthijs L Janssen[SUP] 3 4 5 [/SUP], Gemma Weijsters[SUP] 2 [/SUP], Julia C Berentschot[SUP] 5 [/SUP], Rita J G van den Berg-Emons[SUP] 6 [/SUP], Majanka H Heijenbrok-Kal[SUP] 6 7 [/SUP], Gerard M Ribbers[SUP] 6 7 [/SUP], Joachim Aerts[SUP] 5 [/SUP], Wessel E J J Hanselaar[SUP] 2 [/SUP], Henrik Endeman[SUP] 4 [/SUP], Merel E Hellemons[SUP] 5 [/SUP], Evert-Jan Wils[SUP] 3 4 [/SUP]; CO-FLOW collaboration group; Dutch HFNO COVID-19 study group; On behalf of



Collaborators, Collaborators, Affiliations
Free article Abstract

Objectives: To investigate the association between COVID-19 disease severity during hospitalisation for COVID-19 and long-term multidimensional patient-centred outcomes up to 12 months post-hospitalisation. The secondary objective was to identify other risk factors for these long-term outcomes.
Methods: In this multicentre prospective cohort study, we categorised COVID-19 disease severity using the maximal level of respiratory support as proxy into (1) conventional oxygen therapy (COT), (2) high-flow nasal oxygen (HFNO) and (3) invasive mechanical ventilation (IMV). The primary outcome health-related quality of life (HRQoL), and the secondary outcomes self-reported symptoms and recovery were collected at 6 and 12 months post-hospitalisation.
Results: Data from 777 patients were analysed, with 226 (29%) receiving COT, 273 (35%) HFNO and 278 (36%) IMV. Patients reported impaired HRQoL, persistence of symptoms and poor recovery. Multivariable generalised estimating equations analysis showed that COVID-19 disease severity was not associated with HRQoL and inconsistently with symptoms; the HFNO group reported poorer recovery. Overall, female sex, younger age and pulmonary history were independent risk factors for outcomes.
Conclusions: COVID-19 disease severity was associated with self-perceived recovery, but not with HRQoL and inconsistently with symptoms. Our findings suggest that age, sex and pulmonary history are more consistent risk factors for long-term multidimensional outcomes and offer better guidance for aftercare strategies.

Keywords: COVID-19; Critical Care; Patient Outcome Assessment; Respiratory Infection.

 
Back
Top Bottom